BioSyent Inc.
RX.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 14.93M | 12.11M | 11.08M | 12.63M | 12.72M |
Total Receivables | 3.61M | 3.81M | 2.08M | 3.27M | 4.26M |
Inventory | 3.56M | 3.67M | 3.70M | 4.19M | 4.41M |
Prepaid Expenses | 325.20K | 337.20K | 140.40K | 290.10K | 592.50K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 4.00K | 16.50K | 16.10K |
Total Current Assets | 22.43M | 19.93M | 17.01M | 20.39M | 21.99M |
|
|||||
Total Current Assets | 22.43M | 19.93M | 17.01M | 20.39M | 21.99M |
Net Property, Plant & Equipment | 777.00K | 769.90K | 1.64M | 903.20K | 933.10K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 3.44M | 3.35M | 6.89M | 4.05M | 694.30K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 480.40K | 490.40K | 894.80K | 537.50K | 549.70K |
Total Assets | 31.89M | 29.75M | 28.75M | 33.66M | 30.31M |
|
|||||
Total Accounts Payable | 2.79M | 3.31M | 2.78M | 4.63M | 3.27M |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 151.80K | 140.40K | 136.70K | 141.80K | 137.50K |
Total Finance Division Other Current Liabilities | 754.90K | 618.20K | 840.60K | 437.90K | 181.00K |
Total Other Current Liabilities | 754.90K | 618.20K | 840.60K | 437.90K | 181.00K |
Total Current Liabilities | 3.70M | 4.07M | 3.76M | 5.21M | 3.59M |
|
|||||
Total Current Liabilities | 3.70M | 4.07M | 3.76M | 5.21M | 3.59M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 539.00K | 548.50K | 584.60K | 660.90K | 688.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 85.90K | 80.20K | 76.50K | 146.10K | 153.40K |
Total Liabilities | 4.32M | 4.70M | 4.42M | 6.01M | 4.43M |
|
|||||
Common Stock & APIC | 5.18M | 4.81M | 5.17M | 5.39M | 5.20M |
Retained Earnings | 22.52M | 20.36M | 19.27M | 22.40M | 20.81M |
Treasury Stock & Other | -131.40K | -119.80K | -119.20K | -150.10K | -129.30K |
Total Common Equity | 27.57M | 25.05M | 24.33M | 27.64M | 25.88M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 27.57M | 25.05M | 24.33M | 27.64M | 25.88M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 27.57M | 25.05M | 24.33M | 27.64M | 25.88M |
|